Acquired gray platelet syndrome associated with primary myelofibrosis

4Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

A 53-year-old man presented with uncontrolled bleeding caused by acquired platelet dysfunction accompanied by calreticulin-mutated primary myelofibrosis. Based on the detection of abnormal platelets, including large gray platelets, under light microscopy and the loss of the second wave of aggregation observed by light transmission aggregometry, the patient was diagnosed with platelet dysfunction accompanied by myeloproliferative neoplasms (MPNs). In addition, the absence of platelet ?-granules was confirmed by electron microscopy. Therefore, this condition may be termed "acquired gray platelet syndrome." Acquired platelet dysfunction must be ruled out when abnormal platelets are observed in patients with MPNs.

Cite

CITATION STYLE

APA

Ido, K., Nakane, T., Tanizawa, N., Makuuchi, Y., Okamura, H., Koh, S., … Nakamae, H. (2020). Acquired gray platelet syndrome associated with primary myelofibrosis. Internal Medicine, 59(21), 2751–2756. https://doi.org/10.2169/internalmedicine.4912-20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free